Corvus Pharmaceuticals
CRVS
CRVS
49 hedge funds and large institutions have $62.8M invested in Corvus Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.9% less ownership
Funds ownership: 58.13% → 53.24% (-4.9%)
80% less call options, than puts
Call options by funds: $93K | Put options by funds: $462K
Holders
49
Holding in Top 10
1
Calls
$93K
Puts
$462K
Top Buyers
| 1 | +$3.96M | |
| 2 | +$3.96M | |
| 3 | +$1.1M | |
| 4 |
Two Sigma Investments
New York
|
+$1.07M |
| 5 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$1.04M |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$411K | |
| 3 | -$219K | |
| 4 |
Goldman Sachs
New York
|
-$157K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$151K |